Skip to Content

Cencora Inc COR

Morningstar Rating
$239.13 +1.83 (0.77%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Cencora Continues to See Robust Growth From GLP-1s at the Cost of Margin Depression

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual U.S. healthcare distribution sales, the company supplies roughly one third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.

Price vs Fair Value

COR is trading at a 30% premium.
Price
$237.30
Fair Value
$129.00
Uncertainty
Medium
1-Star Price
$882.22
5-Star Price
$882.40
Economic Moat
Dmcdvm
Capital Allocation
Bbrwrks

Bulls Say, Bears Say

Bulls

Cencora distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$237.30
Day Range
$236.98239.91
52-Week Range
$163.37246.75
Bid/Ask
$232.19 / $250.84
Market Cap
$47.65 Bil
Volume/Avg
1.4 Mil / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
18.89
Price/Sales
0.18
Dividend Yield (Trailing)
0.84%
Dividend Yield (Forward)
0.86%
Total Yield
2.44%

Company Profile

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
46,000

Competitors

Valuation

Metric
COR
MCK
CAH
Price/Earnings (Normalized)
18.8918.2515.50
Price/Book Value
51.92
Price/Sales
0.180.230.12
Price/Cash Flow
14.8214.9411.05
Price/Earnings
COR
MCK
CAH

Financial Strength

Metric
COR
MCK
CAH
Quick Ratio
0.480.480.43
Current Ratio
0.880.920.98
Interest Coverage
9.4114.7218.37
Quick Ratio
COR
MCK
CAH

Profitability

Metric
COR
MCK
CAH
Return on Assets (Normalized)
4.19%6.00%3.89%
Return on Equity (Normalized)
574.41%
Return on Invested Capital (Normalized)
48.08%66.76%89.85%
Return on Assets
COR
MCK
CAH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpRxnfxmlcLprglqc$68.2 Bil
CAH
Cardinal Health IncSrpgyghbJvqflr$25.8 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HKhsvw$8.0 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HHlnfbd$8.0 Bil
SHTDY
Sinopharm Group Co Ltd ADRLpypmhv$7.9 Bil
SHTDF
Sinopharm Group Co LtdDmhqzqc$7.9 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoFxjqdj$7.5 Bil
MAHLY
Medipal Holdings Corp ADRGmvy$3.2 Bil
MEPDF
Medipal Holdings CorpYkkl$3.2 Bil

Sponsor Center